BioRestorative Therapies, Inc.·4

Feb 15, 4:13 PM ET

Silva Francisco 4

4 · BioRestorative Therapies, Inc. · Filed Feb 15, 2024

Insider Transaction Report

Form 4
Period: 2024-02-13
Silva Francisco
VP of Research and Development
Transactions
  • Award

    Stock Option

    2024-02-13+394,737394,737 total
    Exercise: $1.45Exp: 2034-02-13Common Stock (394,737 underlying)
Holdings
  • Common Stock

    164,644
  • Common Stock

    (indirect: By IRA)
    12,136
  • Stock Option

    Exercise: $3000.00Exp: 2024-02-18Common Stock (3 underlying)
    3
  • Stock Option

    Exercise: $3000.00From: 2014-03-12Exp: 2024-03-11Common Stock (1 underlying)
    1
  • Stock Option

    Exercise: $3000.00Exp: 2024-10-23Common Stock (9 underlying)
    9
  • Stock Option

    Exercise: $3000.00Exp: 2025-09-04Common Stock (6 underlying)
    6
  • Stock Option

    Exercise: $3000.00Exp: 2026-06-10Common Stock (15 underlying)
    15
  • Stock Option

    Exercise: $3000.00Exp: 2027-07-12Common Stock (20 underlying)
    20
  • Stock Option

    Exercise: $3000.00Exp: 2028-10-29Common Stock (25 underlying)
    25
  • Stock Option

    Exercise: $5.08Exp: 2031-03-18Common Stock (293,479 underlying)
    293,479
  • Stock Option

    Exercise: $5.08Exp: 2031-11-04Common Stock (42,059 underlying)
    42,059
  • Stock Option

    Exercise: $2.91Exp: 2033-02-17Common Stock (106,762 underlying)
    106,762
Footnotes (5)
  • [F1]Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024.
  • [F2]The option is currently exercisable.
  • [F3]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
  • [F4]The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.
  • [F5]The option vests and becomes exercisable to the extent of 197,369 shares on February 13, 2024 and 197,368 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested.

Documents

1 file
  • 4
    form4.xmlPrimary